Chemoinformaics analysis of 2,6,6,11-TETRAMETHYLTRICYCLO[5.4.0.02,8]UNDEC-10-EN-9-ONE
| Molecular Weight | 218.34 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 24 |
| Exact Molecular Weight | 218.167 | nRing | 4 |
| Solubility: LogS | -4.012 | nHRing | 0 |
| Solubility: LogP | 3.123 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.748 |
| Synth | 3.958 |
| Natural Product Likeliness | 1.944 |
| NR-PPAR-gamma | 0.373 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.966 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.842 |
| MDCK | 0.0000252 |
| BBB | 0.596 |
| PPB | 0.864204 |
| VDSS | 0.68 |
| FU | 0.117705 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.152 |
| CYP2c19-inh | 0.261 |
| CYP2c19-sub | 0.77 |
| CYP2c9-inh | 0.631 |
| CYP2c9-sub | 0.666 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.447 |
| CYP3a4-inh | 0.385 |
| CYP3a4-sub | 0.777 |
| CL | 4.227 |
| T12 | 0.205 |
| hERG | 0.042 |
| Ames | 0.418 |
| ROA | 0.789 |
| SkinSen | 0.063 |
| Carcinogencity | 0.303 |
| EI | 0.011 |
| Respiratory | 0.083 |
| NR-Aromatase | 0.711 |
| Antiviral | Yes |
| Prediction | 0.897098 |